Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

OVIDOvid Therapeutics Inc.

Nasdaq · CIK 0001636651
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts283

Identity from submissions API

NameOvid Therapeutics Inc.
CIK0001636651
TickersOVID
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN465270895
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone212-776-4381
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
441 NINTH AVENUE, 14TH FLOOR
NEW YORK
NY
10001
NY
Mailing address
441 NINTH AVENUE, 14TH FLOOR
NEW YORK
NY
10001
NY

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

538 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-17 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-003565 333-299946 261567925 33 1724
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-128698 005-90350 261563699 34 11921
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001346824-26-000289 005-90350 261562875 34 15032
2026-11-10 S-3 S-3 0001193125-26-454506 333-299946 261538115 33 1333203 1 1
2026-11-10 10-Q 10-Q 0001628280-26-072495 001-38085 261537909 34 18168515 1 1
2026-11-10 8-K 8-K 2.02,9.01 0001628280-26-072494 001-38085 261537893 34 247059 1 1
2026-08-24 144 xsl144X01/primary_doc.xml 0001311404-26-000007 001-38085 261311225 33 6635
2026-08-14 144 xsl144X01/primary_doc.xml 0001311404-26-000005 001-38085 261284178 33 10433
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-097342 005-90350 261283531 34 13877
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001231919-26-000926 005-90350 261283075 34 15527
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001580642-26-005303 005-90350 261278173 34 12247
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-003432 005-90350 261275839 34 15870
2026-08-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001011438-26-000510 005-90350 261273302 34 10192
2026-08-13 10-Q 10-Q 0001628280-26-056498 001-38085 261270210 34 9795357 1 1
2026-08-13 8-K 8-K 9.01 0001628280-26-056497 001-38085 261270206 34 246735 1 1
2026-07-29 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-002922 005-90350 261216981 34 10763
2026-07-08 4 xslF345X06/form4-07082026_080741.xml 0001779359-26-000004 5158
2026-07-08 3 xslF345X06/form3-07082026_080713.xml 0001779359-26-000002 12309
2026-07-08 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001623632-26-000990 005-90350 261160780 34 45771
2026-07-08 8-K 8-K 5.02 0001628280-26-047584 001-38085 261160752 34 149911 1 1
2026-06-17 4 xslF345X06/form4-06172026_080618.xml 0002138163-26-000005 5565
2026-06-17 3 xslF345X06/form3-06172026_080636.xml 0002138163-26-000003 8485
2026-06-11 8-K 8-K 5.07 0001628280-26-042396 001-38085 261081584 34 154345 1 1
2026-06-03 8-K 8-K 5.02 0001628280-26-040038 001-38085 261058901 34 146090 1 1
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-003481 005-90350 26988079 34 13354
2026-05-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001580642-26-003200 005-90350 26984519 34 15260
2026-05-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-003209 005-90350 26982401 34 17401
2026-05-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-225184 005-90350 26982019 34 127416
2026-05-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001256153-26-000006 005-90350 26979482 34 7044
2026-05-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001011438-26-000317 005-90350 26979215 34 9739
2026-05-12 10-Q 10-Q 0001628280-26-033864 001-38085 26965843 34 8670180 1 1
2026-05-12 8-K 8-K 9.01 0001628280-26-033859 001-38085 26965825 34 245662 1 1
2026-04-27 ARS ARS 0001628280-26-027625 001-38085 26901979 34 17964299
2026-04-27 DEFA14A DEFA14A 0001628280-26-027624 001-38085 26901971 34 721602 1 1
2026-04-27 DEF 14A DEF 14A 0001628280-26-027621 001-38085 26901966 34 2677412 1 1
2026-04-27 424B3 424B3 0001193125-26-182352 333-295218 26901883 33 156745
2026-04-24 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001333 333-295218 26896320 33 1723
2026-04-23 CORRESP filename1.htm 0001193125-26-174064 7334
2026-04-23 UPLOAD filename1.pdf 0000000000-26-004178 333-295218 148884
2026-04-21 S-3 S-3 0001193125-26-166974 333-295218 26879965 33 397446 1 1
2026-04-20 8-K 8-K 8.01 0001628280-26-025926 001-38085 26873426 34 140995 1 1
2026-04-09 4 xslF345X06/form4-04092026_050404.xml 0001202098-26-000004 5237
2026-04-09 4 xslF345X06/form4-04092026_050403.xml 0001368324-26-000004 5267
2026-04-09 4 xslF345X06/form4-04092026_050401.xml 0001886431-26-000004 5238
2026-03-25 4 xslF345X06/form4-03262026_010323.xml 0001256153-26-000004 8121
2026-03-18 S-8 S-8 0001628280-26-019463 333-294418 26770025 33 678874 1 1
2026-03-18 10-K 10-K 0001628280-26-019438 001-38085 26769481 34 30053586 1 1
2026-03-18 8-K 8-K 1.01,2.02,3.02,9.01 0001628280-26-019045 001-38085 26765319 34 27808399 1 1
2026-03-02 4 xslF345X05/form4-03022026_040303.xml 0002036798-26-000004 7989
2026-03-02 4 xslF345X05/form4-03022026_040315.xml 0001202098-26-000002 5379
2026-03-02 4 xslF345X05/form4-03022026_040313.xml 0001886431-26-000002 5383
2026-03-02 4 xslF345X05/form4-03022026_040301.xml 0001256153-26-000002 5427
2026-03-02 4 xslF345X05/form4-03022026_040311.xml 0001368324-26-000002 5407
2026-03-02 4 xslF345X05/form4-03022026_040309.xml 0001353128-26-000002 5482
2026-03-02 4 xslF345X05/form4-03022026_040307.xml 0001654055-26-000002 5385
2026-03-02 4 xslF345X05/form4-03022026_040305.xml 0001311404-26-000002 9973
2026-02-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-26-016662 005-90350 26644810 34 17854
2026-01-29 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001315863-26-000096 005-90350 26579978 34 14914
2026-01-08 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001623632-26-000052 005-90350 26518252 34 45561
2026-01-05 4 xslF345X05/form4-01052026_050101.xml 0002036798-26-000002 5536
2026-01-05 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-26-000036 005-90350 26506155 34 18872
2025-12-22 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-003891 333-292151 251594572 33 1724
2025-12-22 424B3 424B3 0001193125-25-328805 333-292151 251592821 33 184439
2025-12-19 CORRESP filename1.htm 0001193125-25-327040 7064
2025-12-18 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001346824-25-000079 005-90350 251584494 34 19685
2025-12-18 4 xslF345X05/form4-12182025_041203.xml 0001256153-25-000004 15759
2025-12-18 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001315863-25-000859 005-90350 251583087 34 13732
2025-12-18 8-K 8-K 8.01,9.01 0001193125-25-323798 001-38085 251581396 34 174435 1 1
2025-12-15 S-3 S-3 0001193125-25-319453 333-292151 251572599 33 416579 1 1
2025-12-11 8-K 8-K 5.07 0001636651-25-000017 001-38085 251564450 34 154252 1 1
2025-12-09 4 FORM 4 0001395064-25-000172 10203
2025-12-09 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001395064-25-000167 005-90350 251560620 34 20587
2025-12-08 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000340 005-90350 251555166 34 9861
2025-11-12 10-Q 10-Q 0001636651-25-000012 001-38085 251468681 34 7514932 1 1
2025-11-12 8-K 8-K 2.02,5.02,9.01 0001636651-25-000011 001-38085 251468655 34 267401 1 1
2025-11-07 DEF 14A DEF 14A 0001140361-25-040884 001-38085 251460274 34 1796843
2025-10-28 PRE 14A PRE 14A 0001140361-25-039516 001-38085 251421156 34 1680700
2025-10-27 PREM14A PREM14A 0001140361-25-039497 001-38085 251420735 34 1678943
2025-10-03 8-K 8-K 1.01,3.02,5.03,8.01,9.01 0001193125-25-230409 001-38085 251374919 34 1166306 1 1
2025-09-16 8-K 8-K 8.01 0001193125-25-204308 001-38085 251315855 34 134620 1 1
2025-08-13 10-Q 10-Q 0001628280-25-040008 001-38085 251209053 34 7272721 1 1
2025-08-13 8-K 8-K 9.01 0001628280-25-040007 001-38085 251209049 34 258758 1 1
2025-07-21 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000921895-25-002008 005-90350 251138286 34 19750
2025-07-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-003245 005-90350 251132365 34 10682
2025-07-10 8-K 8-K 5.07 0001628280-25-034733 001-38085 251116593 34 160131 1 1
2025-07-09 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-066702 005-90350 251113691 34 10247
2025-06-25 8-K 8-K 8.01 0001628280-25-032959 001-38085 251071096 34 209575 1 1
2025-06-18 4 xslF345X05/form4-06182025_040608.xml 0001415889-25-017698 5379
2025-06-18 4 xslF345X05/form4-06182025_040606.xml 0001415889-25-017697 5364
2025-06-18 4 xslF345X05/form4-06182025_040603.xml 0001415889-25-017696 5376
2025-06-18 4 xslF345X05/form4-06182025_040601.xml 0001415889-25-017695 5376
2025-05-22 ARS ARS 0001628280-25-027149 001-38085 25974769 34 2014292
2025-05-22 DEFA14A DEFA14A 0001628280-25-027148 001-38085 25974766 34 323914
2025-05-22 DEF 14A DEF 14A 0001628280-25-027146 001-38085 25974763 34 3133755 1 1
2025-05-13 10-Q 10-Q 0001628280-25-024913 001-38085 25937255 34 6719947 1 1
2025-05-13 8-K 8-K 2.02 0001628280-25-024911 001-38085 25937243 34 258163 1 1
2025-05-02 8-K 8-K 5.08 0001193125-25-111633 001-38085 25908701 34 147093 1 1
2025-05-02 PRE 14A PRE 14A 0001628280-25-021830 001-38085 25908512 34 3144840 1 1
2025-04-30 10-K/A 10-K/A 0001628280-25-021055 001-38085 25894979 34 980651 1 1
2025-03-11 10-K 10-K 0001628280-25-011844 001-38085 25726023 34 15805833 1 1
2025-03-11 8-K 8-K 2.02 0001628280-25-011839 001-38085 25725982 34 284147 1 1
2025-03-05 8-K 8-K 5.02 0001193125-25-047174 001-38085 25710988 34 149288 1 1
2025-03-04 4 xslF345X05/form4-03042025_090327.xml 0001415889-25-006568 5406
2025-03-04 3 xslF345X02/form3-03042025_090338.xml 0001415889-25-006566 10070
2025-02-28 4 xslF345X05/form4-02282025_040204.xml 0001415889-25-005998 5124
2025-02-28 4 xslF345X05/form4-02282025_040201.xml 0001415889-25-005997 5032
2025-02-24 4 xslF345X05/form4-02242025_070206.xml 0001415889-25-005368 5309
2025-02-24 4 xslF345X05/form4-02242025_070203.xml 0001415889-25-005367 7331
2025-02-24 4 xslF345X05/form4-02242025_070201.xml 0001415889-25-005366 7423
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001013594-25-000311 005-90350 25631366 34 13740
2025-02-13 8-K 8-K 3.01 0001193125-25-026192 001-38085 25621617 34 146852 1 1
2025-01-29 4 xslF345X05/form4-01292025_020104.xml 0001415889-25-002230 4593
2024-12-16 4 xslF345X05/form4-12162024_041217.xml 0001415889-24-029474 11179
2024-12-16 4 xslF345X05/form4-12162024_041215.xml 0001415889-24-029473 11158
2024-12-16 4 xslF345X05/form4-12162024_041213.xml 0001415889-24-029472 11172
2024-12-16 4 xslF345X05/form4-12162024_041211.xml 0001415889-24-029471 11166
2024-11-14 SC 13G/A ovid13ga3.htm 0000935836-24-000717 005-90350 241464866 34 47000
2024-11-14 SC 13G/A AMENDMENT NO. 5 TO SCHEDULE 13G 0000921895-24-002737 005-90350 241463518 34 276854
2024-11-12 10-Q 10-Q 0001628280-24-046868 001-38085 241443572 34 11550358 1 1
2024-11-12 8-K 8-K 9.01 0001628280-24-046867 001-38085 241443530 34 263032 1 1
2024-09-11 4 xslF345X05/form4-09112024_090958.xml 0001415889-24-023237 5546
2024-09-11 3 xslF345X02/form3-09112024_090933.xml 0001415889-24-023235 19660
2024-09-11 8-K 8-K 5.02,9.01 0001193125-24-217302 001-38085 241293170 34 273322 1 1
2024-08-13 10-Q 10-Q 0001628280-24-036860 001-38085 241198854 34 6506948 1 1
2024-08-13 8-K 8-K 9.01 0001628280-24-036859 001-38085 241198850 34 264935 1 1
2024-08-02 8-K 10-Q 5.02 0001628280-24-034481 001-38085 241172286 34 154537 1 1
2024-08-01 4 xslF345X05/form4-08012024_050801.xml 0001415889-24-020526 11364
2024-07-01 8-K 8-K 8.01 0001628280-24-030546 001-38085 241088227 34 255229 1 1
2024-06-28 8-K 8-K 2.05,5.02,7.01 0001193125-24-172225 001-38085 241085487 34 153155 1 1
2024-06-17 8-K 8-K 7.01,9.01 0000950170-24-073998 001-38085 241046936 34 248341 1 1
2024-06-07 8-K 8-K 5.07 0000950170-24-070673 001-38085 241029792 34 173822 1 1
2024-05-14 S-8 S-8 0001193125-24-138390 333-279405 24945799 33 70179
2024-05-14 10-Q 10-Q 0001628280-24-023067 001-38085 24941535 34 15539571 1 1
2024-05-14 8-K 8-K 2.02,9.01 0001628280-24-023064 001-38085 24941511 34 250794 1 1
2024-04-24 ARS ARS 0000950170-24-047688 001-38085 24871357 34 2406120
2024-04-24 DEFA14A DEFA14A 0000950170-24-047676 001-38085 24871338 34 1238104
2024-04-24 DEF 14A DEF 14A 0000950170-24-047673 001-38085 24871330 34 6621737 1 1
2024-03-20 4 FORM 4 SUBMISSION 0001209191-24-005001 6169
2024-03-08 10-K 10-K 0001628280-24-009809 001-38085 24732421 34 32171310 1 1
2024-03-08 8-K 8-K 2.02 0001628280-24-009807 001-38085 24732415 34 275906 1 1
2024-02-26 4 FORM 4 SUBMISSION 0001209191-24-003972 7651
2024-02-26 4 FORM 4 SUBMISSION 0001209191-24-003970 7630
2024-02-26 4 FORM 4 SUBMISSION 0001209191-24-003968 5426
2024-02-26 4 FORM 4 SUBMISSION 0001209191-24-003966 7676
2024-02-26 4 FORM 4 SUBMISSION 0001209191-24-003964 5407
2024-02-26 4 FORM 4 SUBMISSION 0001209191-24-003962 5387
2024-02-26 4 FORM 4 SUBMISSION 0001209191-24-003960 5405
2024-02-26 4 FORM 4 SUBMISSION 0001209191-24-003958 5400
2024-02-26 4 FORM 4 SUBMISSION 0001209191-24-003956 5401
2024-02-14 SC 13G/A SC 13G/A 0001104659-24-023663 005-90350 24638405 34 39932
2024-02-14 4/A xslF345X05/form4a-02142024_040202.xml 0001415889-24-003721 5667
2024-02-14 SC 13G/A ovid13ga-02142024.htm 0001013594-24-000175 005-90350 24634195 34 103694
2024-02-12 SC 13G/A SC 13G/A 0001104659-24-013559 005-90350 24617233 34 71462
2024-01-29 SC 13G us6904691010_012924.txt 0001086364-24-005579 005-90350 24574882 34 13317
2023-12-06 8-K 8-K 8.01 0000950170-23-068591 001-38085 231470434 34 150481 1 1
2023-12-06 4 FORM 4 SUBMISSION 0001209191-23-057640 7956
2023-11-15 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-11-15 16:00:00 9999999995-23-003334 333-275307 231412310 33 1682
2023-11-15 424B5 424B5 0001193125-23-277893 333-275307 231410673 33 477846
2023-11-13 CORRESP filename1.htm 0001193125-23-275752 9055
2023-11-08 UPLOAD filename1.pdf 0000000000-23-012266 40251
2023-11-03 S-3 S-3 0001193125-23-270373 333-275307 231376391 33 1489942
2023-11-03 10-Q 10-Q 0001628280-23-036564 001-38085 231374547 34 6555411 1 1
2023-11-03 8-K 8-K 2.02,9.01 0001628280-23-036563 001-38085 231374543 34 273894 1 1
2023-10-18 8-K 8-K 1.01,7.01,8.01,9.01 0000950170-23-053875 001-38085 231330945 34 225732 1 1
2023-10-02 8-K 8-K 8.01,9.01 0000950170-23-050995 001-38085 231298570 34 52265080 1 1
2023-08-04 10-Q 10-Q 0001628280-23-027430 001-38085 231142397 34 6004177 1 1
2023-08-04 8-K 8-K 2.02 0001628280-23-027426 001-38085 231142374 34 270703 1 1
2023-07-31 SC 13G ovid13g-07242023.htm 0001013594-23-000620 005-90350 231128498 34 121155
2023-06-09 8-K 8-K 5.07 0000950170-23-027151 001-38085 231003982 34 221037 1 1
2023-05-05 S-8 S-8 0001193125-23-137265 333-271704 23895139 33 68185
2023-05-05 10-Q 10-Q 0001628280-23-016013 001-38085 23891581 34 5823641 1 1
2023-05-05 8-K 8-K 2.02,9.01 0001628280-23-015996 001-38085 23891390 34 285333 1 1
2023-05-01 8-K 8-K 8.01,9.01 0000950170-23-016250 001-38085 23873925 34 252944 1 1
2023-04-27 8-K 8-K 8.01,9.01 0000950170-23-015343 001-38085 23857899 34 239055 1 1
2023-04-27 ARS ARS 0000950170-23-014924 001-38085 23851034 34 1894533
2023-04-27 DEF 14A DEF 14A 0000950170-23-014914 001-38085 23851000 34 4885475
2023-04-26 DEFA14A DEFA14A 0000950170-23-014910 001-38085 23850975 34 1755738
2023-03-13 10-K 10-K 0001628280-23-007648 001-38085 23725993 34 8002231 1 1
2023-03-13 8-K 8-K 2.02 0001628280-23-007636 001-38085 23725804 34 291951 1 1
2023-03-10 8-K 8-K 7.01 0001628280-23-007568 001-38085 23724426 34 178121 1 1
2023-02-27 4 FORM 4 SUBMISSION 0001209191-23-013309 5420
2023-02-27 4 FORM 4 SUBMISSION 0001209191-23-013301 5404
2023-02-27 4 FORM 4 SUBMISSION 0001209191-23-013251 5331
2023-02-27 4 FORM 4 SUBMISSION 0001209191-23-013239 5445
2023-02-27 4 FORM 4 SUBMISSION 0001209191-23-013236 5312
2023-02-27 4 FORM 4 SUBMISSION 0001209191-23-013229 5292
2023-02-27 4 FORM 4 SUBMISSION 0001209191-23-013215 5310
2023-02-27 4 FORM 4 SUBMISSION 0001209191-23-013207 5305
2023-02-27 4 FORM 4 SUBMISSION 0001209191-23-013203 5306
2023-02-14 SC 13G/A AMENDMENT TO FORM SC 13G 0001839882-23-003736 005-90350 23628491 34 65203
2023-02-14 SC 13G/A AMENDMENT NO. 4 TO THE SCHEDULE 13G 0000921895-23-000480 005-90350 23620716 34 277145
2023-02-13 SC 13G/A ovid13ga.htm 0000935836-23-000135 005-90350 23615463 34 60365
2023-02-10 SC 13G SC 13G 0001104659-23-018479 005-90350 23611639 34 67031
2023-02-10 SC 13G/A ovid13ga.htm 0000935836-23-000105 005-90350 23610592 34 47287
2023-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-23-016662 005-90350 23604001 34 12954
2023-02-03 SC 13G/A SC 13G/A 0001395064-23-000010 005-90350 23584509 34 76574
2022-11-08 10-Q 10-Q 0001628280-22-028772 001-38085 221367404 34 6735232 1 1
2022-11-08 8-K 8-K 2.02 0001628280-22-028771 001-38085 221367400 34 297340 1 1
2022-09-14 4 FORM 4 SUBMISSION 0001209191-22-049938 4869
2022-08-09 10-Q 10-Q 0001628280-22-021759 001-38085 221146530 34 6626489 1 1
2022-08-09 8-K 8-K 2.02,9.01 0001628280-22-021758 001-38085 221146521 34 290945 1 1
2022-07-06 4 FORM 4 0001395064-22-000121 15446
2022-06-10 8-K 8-K 5.07 0000950170-22-011472 001-38085 221008814 34 196606 1 1
2022-05-11 8-K 8-K 8.01,9.01 0000950170-22-009147 001-38085 22912149 34 183887 1 1
2022-05-10 10-Q 10-Q 0000950170-22-008739 001-38085 22907484 34 8037061 1 1
2022-05-10 8-K 8-K 2.02,9.01 0000950170-22-008734 001-38085 22907459 34 408557 1 1
2022-05-02 DEFA14A DEFA14A 0000950170-22-006763 001-38085 22879297 34 458880
2022-04-29 DEF 14A DEF 14A 0000950170-22-006707 001-38085 22875054 34 1580893
2022-04-12 4 FORM 4 SUBMISSION 0001209191-22-024198 5455
2022-04-12 4 FORM 4 SUBMISSION 0001209191-22-024191 7953
2022-04-12 4 FORM 4 SUBMISSION 0001209191-22-024189 5354
2022-04-12 4 FORM 4 SUBMISSION 0001209191-22-024187 7943
2022-04-12 4 FORM 4 SUBMISSION 0001209191-22-024185 7975
2022-04-12 4 FORM 4 SUBMISSION 0001209191-22-024163 5468
2022-04-12 4 FORM 4 SUBMISSION 0001209191-22-024159 5469
2022-03-16 S-8 POS S-8 POS 0001193125-22-077218 333-263562 22744837 33 36747
2022-03-15 S-8 S-8 0001193125-22-076005 333-263562 22741029 33 74053
2022-03-15 10-K 10-K 0000950170-22-003668 001-38085 22739232 34 10574352 1 1
2022-03-15 8-K 8-K 2.02,9.01 0000950170-22-003665 001-38085 22739213 34 345858 1 1
2022-02-14 SC 13G/A AMENDMENT TO FORM SC 13G 0001839882-22-002943 005-90350 22635227 34 56054
2022-02-14 SC 13G/A AMENDMENT TO FORM SC 13G 0001387131-22-001913 005-90350 22633012 34 69522
2022-02-14 SC 13G/A ovidtherapeutics13ga.htm 0000935836-22-000167 005-90350 22630396 34 47242
2022-02-14 SC 13G/A ovidtherapeutics13ga.htm 0000935836-22-000108 005-90350 22623162 34 60714
2022-02-10 SC 13G SCHEDULE 13G 0001104659-22-018273 005-90350 22610582 34 12924
2022-02-04 4 FORM 4 SUBMISSION 0001209191-22-007329 5340
2022-02-04 4 FORM 4 SUBMISSION 0001209191-22-007328 5301
2022-02-04 4 FORM 4 SUBMISSION 0001209191-22-007327 5319
2022-02-04 4 FORM 4 SUBMISSION 0001209191-22-007326 5314
2022-02-04 4 FORM 4 SUBMISSION 0001209191-22-007325 5315
2022-02-04 4 FORM 4 SUBMISSION 0001209191-22-007314 5429
2022-02-04 4 FORM 4 SUBMISSION 0001209191-22-007311 5413
2022-02-04 4 FORM 4 SUBMISSION 0001209191-22-007310 5454
2022-02-04 4 FORM 4 SUBMISSION 0001209191-22-007305 5321
2022-01-03 8-K 8-K 1.01,3.02,7.01,9.01 0001564590-22-000016 001-38085 22500367 34 916498 1 1
2021-11-10 10-Q 10-Q 0000950170-21-004066 001-38085 211396454 34 9260988 1 1
2021-11-10 8-K 8-K 2.02,7.01,9.01 0001193125-21-325375 001-38085 211394580 34 234024 1 1
2021-10-07 4 FORM 4 SUBMISSION 0001209191-21-059940 5517
2021-10-07 3 FORM 3 SUBMISSION 0001209191-21-059929 2930
2021-10-07 8-K 8-K 5.02 0001564590-21-050376 001-38085 211311119 34 167000 1 1
2021-08-18 8-K 8-K 7.01,9.01 0001564590-21-044971 001-38085 211185047 34 7160738 1 1
2021-08-16 8-K 8-K 2.02,9.01 0001564590-21-044455 001-38085 211174626 34 1456421
2021-08-16 10-Q 10-Q 0000950170-21-001457 001-38085 211173560 34 8200561 1 1
2021-08-11 8-K/A 8-K/A 5.02 0001564590-21-043544 001-38085 211164737 34 30289
2021-07-16 4 FORM 4 SUBMISSION 0001209191-21-046995 9106
2021-07-13 4 FORM 4 SUBMISSION 0001209191-21-046497 9788
2021-07-12 3 FORM 3 SUBMISSION 0001209191-21-046304 7269
2021-07-12 SC 13G us6904691010_071021.txt 0000834237-21-008766 005-90350 211084439 34 12173
2021-07-08 8-K 8-K 5.02 0001564590-21-036074 001-38085 211080564 34 29453
2021-07-01 4 FORM 4 SUBMISSION 0001209191-21-044391 5424
2021-06-23 8-K 8-K 7.01,9.01 0001564590-21-033909 001-38085 211037219 34 6409593
2021-06-11 4 FORM 4 SUBMISSION 0001209191-21-040081 5312
2021-06-11 4 FORM 4 SUBMISSION 0001209191-21-040075 5299
2021-06-11 4 FORM 4 SUBMISSION 0001209191-21-040069 5313
2021-06-11 8-K 8-K 5.07 0001564590-21-032652 001-38085 211011279 34 41189
2021-06-10 4 FORM 4 SUBMISSION 0001209191-21-039670 5431
2021-06-04 8-K 8-K 5.02 0001564590-21-031677 001-38085 21994900 34 31049
2021-05-18 4 FORM 4 SUBMISSION 0001209191-21-033831 5290
2021-05-18 4 FORM 4 SUBMISSION 0001209191-21-033829 5295
2021-05-18 4 FORM 4 SUBMISSION 0001209191-21-033828 5314
2021-05-18 4 FORM 4 SUBMISSION 0001209191-21-033825 5309
2021-05-18 8-K 8-K 7.01,9.01 0001564590-21-028670 001-38085 21935709 34 5618066
2021-05-13 10-Q 10-Q 0001564590-21-027623 001-38085 21920535 34 6526929 1
2021-05-13 8-K 8-K 2.02,9.01 0001564590-21-027612 001-38085 21920309 34 124681
2021-04-30 DEFA14A DEFA14A 0001564590-21-022436 001-38085 21876656 34 534400
2021-04-30 DEF 14A DEF 14A 0001564590-21-022189 001-38085 21873473 34 1203550
2021-04-29 4 FORM 4 SUBMISSION 0001209191-21-029048 5711
2021-04-29 4 FORM 4 SUBMISSION 0001209191-21-029041 5687
2021-04-29 SC 13G ovid13g.htm 0000935836-21-000342 005-90350 21871548 34 61847
2021-04-19 8-K 8-K 7.01,9.01 0001564590-21-019420 001-38085 21834872 34 5652449
2021-04-19 8-K 8-K 8.01,9.01 0001564590-21-019260 001-38085 21833308 34 90423
2021-04-15 SC 13G/A AMENDMENT NO. 3 TO THE SCHEDULE 13G 0000921895-21-001066 005-90350 21828596 34 279622
2021-04-09 8-K 8-K 7.01,9.01 0001564590-21-018257 001-38085 21816774 34 5862619
2021-04-01 8-K 8-K 1.02 0001564590-21-017335 001-38085 21798828 34 26485
2021-03-30 8-K 8-K 8.01,9.01 0001564590-21-016325 001-38085 21783704 34 90692
2021-03-18 CT ORDER filename1.pdf 20210318,20210318 9999999997-21-001227 001-38085 21753126 34 123028
2021-03-18 S-8 S-8 0001193125-21-084391 333-254420 21752540 33 59532
2021-03-15 10-K 10-K 2020 0001564590-21-013016 001-38085 21739912 34 10727885 1
2021-03-15 8-K 8-K 2.02,9.01 0001564590-21-013010 001-38085 21739887 34 155565
2021-03-09 SC 13G/A ovidthera13g.htm 0000935836-21-000231 005-90350 21725268 34 48266
2021-03-09 SC 13G ovidthera13g.htm 0000935836-21-000227 005-90350 21725042 34 48262
2021-03-03 8-K 8-K 7.01,9.01 0001564590-21-010454 001-38085 21707492 34 992251
2021-03-03 8-K 8-K 1.01,1.02 0001564590-21-010415 001-38085 21707206 34 31628
2021-02-17 SC 13G/A CONSONANCE CAPITAL MANAGEMENT LP 0001085146-21-001039 005-90350 21644263 34 55042
2021-02-16 SC 13G/A SC 13G/A 0001193125-21-045021 005-90350 21639635 34 34901
2021-02-16 SC 13G/A SC 13G/A 0001193125-21-045008 005-90350 21639577 34 39637
2021-02-16 SC 13G/A CONSONANCE CAPITAL MANAGEMENT LP 0001085146-21-000929 005-90350 21636235 34 55131
2021-02-12 SC 13G/A AMENDMENT NO. 2 TO THE SCHEDULE 13G 0000921895-21-000381 005-90350 21627737 34 280341
2021-02-08 4 FORM 4 SUBMISSION 0001209191-21-008642 5539
2021-02-02 SC 13G us6904691010_020221.txt 0000834237-21-007063 005-90350 21580803 34 13120
2021-01-05 SC 13G/A SCHEDULE 13G/A 0001170316-21-000003 005-90350 21505099 34 5434
2020-12-21 8-K 8-K 5.02 0001564590-20-057864 001-38085 201405195 34 41510
2020-12-21 4 FORM 4 SUBMISSION 0001209191-20-064678 5432
2020-12-21 4 FORM 4 SUBMISSION 0001209191-20-064674 5456
2020-12-21 4 FORM 4 SUBMISSION 0001209191-20-064666 5433
2020-12-21 4 FORM 4 SUBMISSION 0001209191-20-064665 5475
2020-12-21 4 FORM 4 SUBMISSION 0001209191-20-064657 5323
2020-12-21 4 FORM 4 SUBMISSION 0001209191-20-064649 5491
2020-12-21 4 FORM 4 SUBMISSION 0001209191-20-064645 5446
2020-12-01 8-K 8-K 8.01,9.01 0001564590-20-055762 001-38085 201361687 34 58419
2020-11-20 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2020-11-20 16:00:00 9999999995-20-003262 333-250054 201334175 33 1702
2020-11-20 424B5 424B5 0001193125-20-299425 333-250054 201332799 33 524018
2020-11-18 CORRESP filename1.htm 0001193125-20-297059 8577
2020-11-18 UPLOAD filename1.pdf 0000000000-20-011034 40211
2020-11-13 S-3 S-3 0001193125-20-292202 333-250054 201309086 33 1682442
2020-11-13 10-Q 10-Q 0001564590-20-053666 001-38085 201308411 34 7767738 1
2020-11-12 8-K 8-K 2.02,9.01 0001564590-20-053607 001-38085 201307172 34 151469
2020-10-22 8-K 8-K 7.01,9.01 0001564590-20-047230 001-38085 201253521 34 31282330
2020-10-13 4 FORM 4 SUBMISSION 0001209191-20-054653 5426
2020-10-13 4 FORM 4 SUBMISSION 0001209191-20-054645 5484
2020-10-13 4 FORM 4 SUBMISSION 0001209191-20-054642 5449
2020-10-02 4 FORM 4 SUBMISSION 0001209191-20-053411 9230
2020-10-02 3 FORM 3 SUBMISSION 0001209191-20-053404 7246
2020-09-30 8-K 8-K 8.01,9.01 0001564590-20-045189 001-38085 201210657 34 86966
2020-09-01 4 FORM 4 SUBMISSION 0001209191-20-049011 5524
2020-08-26 8-K 8-K 8.01,9.01 0001193125-20-231250 001-38085 201137321 34 258551
2020-08-26 424B5 424B5 0001193125-20-231241 333-225391 201137277 33 1058043
2020-08-25 8-K 8-K 8.01,9.01 0001564590-20-041092 001-38085 201129544 34 10112763
2020-08-10 10-Q 10-Q 0001564590-20-038644 001-38085 201087226 34 6512906 1
2020-08-10 8-K 8-K 2.02,9.01 0001564590-20-038634 001-38085 201087188 34 183514
2020-07-13 8-K 8-K 1.01 0001564590-20-032209 001-38085 201024287 34 31859
2020-06-23 4 FORM 4 SUBMISSION 0001209191-20-038475 5534
2020-06-19 8-K 8-K 8.01,9.01 0001564590-20-029856 001-38085 20974304 34 54024
2020-06-17 8-K 8-K 7.01,9.01 0001564590-20-029613 001-38085 20969062 34 17710840
2020-06-08 4 FORM 4 SUBMISSION 0001209191-20-035041 5293
2020-06-08 4 FORM 4 SUBMISSION 0001209191-20-035040 5298
2020-06-08 4 FORM 4 SUBMISSION 0001209191-20-035039 5314
2020-06-08 4 FORM 4 SUBMISSION 0001209191-20-035038 5312
2020-06-05 8-K 8-K 5.07 0001564590-20-028515 001-38085 20947207 34 44861
2020-05-27 SC 13D/A efc19-628_sc13d1227.htm 0001768824-20-000003 005-90350 20914046 34 185390
2020-05-13 SC 13D/A efc19-628_sc13d1227.htm 0001768824-20-000001 005-90350 20872587 34 185547
2020-05-07 10-Q 10-Q 0001564590-20-023002 001-38085 20857600 34 5670578 1
2020-05-07 8-K 8-K 2.02,8.01,9.01 0001564590-20-022392 001-38085 20854667 34 215282
2020-04-24 DEFA14A DEFA14A 0001564590-20-018286 001-38085 20812066 34 241149
2020-04-24 DEF 14A DEF 14A 0001564590-20-018268 001-38085 20811997 34 1171982
2020-03-30 8-K 8-K 8.01,9.01 0001564590-20-013857 001-38085 20754072 34 70121
2020-03-27 SC 13G/A SCHEDULE 13G 0001170316-20-000003 005-90350 20748206 34 5428
2020-03-13 8-K 8-K 7.01,9.01 0001564590-20-010659 001-38085 20710867 34 11153901
2020-03-11 S-8 S-8 0001193125-20-070452 333-237098 20706341 33 60048
2020-03-11 10-K 10-K 2019 0001564590-20-010108 001-38085 20705899 34 9077019 1
2020-03-11 8-K 8-K 2.02,9.01 0001564590-20-009878 001-38085 20703913 34 144667
2020-03-02 8-K 8-K 7.01,9.01 0001564590-20-008128 001-38085 20676611 34 11155263
2020-02-14 SC 13G/A AMENDMENT NO. 1 TO THE SCHEDULE 13G 0000921895-20-000516 005-90350 20618094 34 296201
2020-02-14 SC 13G CONSONANCE CAPITAL MANAGEMENT LP 0001085146-20-000790 005-90350 20617852 34 57225
2020-02-14 SC 13G/A d8478272_13g-a.htm 0000919574-20-001524 005-90350 20617375 34 115551
2020-02-14 SC 13G/A SC 13G/A 0001193125-20-036949 005-90350 20614599 34 35997
2020-02-14 SC 13G/A SC 13G/A 0001193125-20-036944 005-90350 20614565 34 35550
2020-01-17 SC 13G/A SCHEDULE 13G 0001170316-20-000002 005-90350 20533539 34 5637
2020-01-07 8-K 8-K 8.01,9.01 0001564590-20-000319 001-38085 20512133 34 69040
2020-01-02 4 FORM 4 SUBMISSION 0001209191-20-000452 5450
2019-12-24 8-K 8-K 5.02 0001564590-19-046730 001-38085 191307600 34 44613
2019-12-20 4 FORM 4 SUBMISSION 0001209191-19-061568 5475
2019-12-20 4 FORM 4 SUBMISSION 0001209191-19-061560 5322
2019-12-20 4 FORM 4 SUBMISSION 0001209191-19-061548 5491
2019-12-20 4 FORM 4 SUBMISSION 0001209191-19-061544 5450
2019-12-20 4 FORM 4 SUBMISSION 0001209191-19-061538 5450
2019-11-27 SC 13D/A AMENDMENT 2 0001768824-19-000008 005-90350 191255841 34 197829
2019-11-22 4 FORM 4 0001395064-19-000083 7472
2019-11-22 SC 13G/A SC 13G/A 0001395064-19-000082 005-90350 191238659 34 88296
2019-11-22 3 FORM 3 0001395064-19-000081 9148
2019-11-22 SC 13G/A SC 13G/A 0001395064-19-000080 005-90350 191238652 34 88689
2019-11-21 4 FORM 4 SUBMISSION 0001209191-19-057557 5432
2019-11-21 3 FORM 3 SUBMISSION 0001209191-19-057556 2947
2019-11-15 4 FORM 4 SUBMISSION 0001209191-19-056750 5296
2019-11-15 4 FORM 4 SUBMISSION 0001209191-19-056745 5301
2019-11-15 4 FORM 4 SUBMISSION 0001209191-19-056741 5320
2019-11-15 4 FORM 4 SUBMISSION 0001209191-19-056735 5315
2019-11-12 424B5 424B5 0001193125-19-289308 333-225391 191206233 33 444691
2019-11-08 10-Q 10-Q 0001564590-19-042028 001-38085 191202184 34 6407925 1
2019-11-08 8-K 8-K 2.02,9.01 0001564590-19-042022 001-38085 191202158 34 174717
2019-11-04 4 FORM 4 SUBMISSION 0001209191-19-055002 5471
2019-11-04 4 FORM 4 SUBMISSION 0001209191-19-055000 5454
2019-11-01 8-K 8-K 5.01,8.01,9.01 0001564590-19-039281 001-38085 191185245 34 54883
2019-10-10 4 FORM 4 SUBMISSION 0001209191-19-052988 6998
2019-10-08 424B5 424B5 0001193125-19-263978 333-225391 191141751 33 1407310
2019-10-08 424B5 424B5 0001193125-19-263977 333-225391 191141749 33 1388421
2019-10-08 8-K FORM 8-K 8.01,9.01 0001193125-19-263976 001-38085 191141744 34 461685
2019-10-07 SC 13D/A efc19-628_sc13da.htm 0001768824-19-000006 005-90350 191140442 34 194097
2019-10-03 424B5 424B5 0001193125-19-261653 333-225391 191135692 33 1408615
2019-10-03 424B5 424B5 0001193125-19-261644 333-225391 191135638 33 1390903
2019-09-24 8-K 8-K 5.03,9.01 0001564590-19-035235 001-38085 191109095 34 185115
2019-09-23 8-K 8-K 7.01,8.01,9.01 0001564590-19-035162 001-38085 191106277 34 7796885
2019-09-19 8-K FORM 8-K 3.02,5.03,5.07,9.01 0001193125-19-248745 001-38085 191100903 34 153063
2019-09-12 8-K 8-K 8.01,9.01 0001564590-19-034545 001-38085 191089544 34 55885
2019-09-09 8-K 8-K 8.01,9.01 0001564590-19-034294 001-38085 191080549 34 15034409
2019-08-07 S-8 S-8 0001193125-19-215523 333-233101 191006581 33 73073
2019-08-07 10-Q Q2 10-Q 0001564590-19-030178 001-38085 191006304 34 6035413 1
2019-08-07 8-K 8-K 2.02,9.01 0001564590-19-030143 001-38085 191006064 34 155781
2019-08-02 4 FORM 4 SUBMISSION 0001209191-19-044363 5292
2019-08-01 4/A FORM 4/A SUBMISSION 0001209191-19-044055 5641
2019-08-01 4/A FORM 4/A SUBMISSION 0001209191-19-044050 5662
2019-08-01 4/A FORM 4/A SUBMISSION 0001209191-19-044045 5660
2019-07-02 8-K 8-K 8.01,9.01 0001564590-19-024285 001-38085 19935295 34 54914
2019-06-27 8-K 8-K 7.01,9.01 0001564590-19-023703 001-38085 19923746 34 33517684
2019-06-27 8-K 8-K 8.01,9.01 0001564590-19-023666 001-38085 19922987 34 74427
2019-06-18 8-K 8-K 8.01,9.01 0001564590-19-022718 001-38085 19902688 34 48609
2019-06-17 8-K/A 8-K/A 1.01,9.01 0001564590-19-022662 001-38085 19901715 34 73025
2019-06-10 8-K 8-K 5.07 0001564590-19-022139 001-38085 19889367 34 41587
2019-06-10 4 FORM 4 SUBMISSION 0001209191-19-035795 5289
2019-06-10 4 FORM 4 SUBMISSION 0001209191-19-035786 5307
2019-06-10 4 FORM 4 SUBMISSION 0001209191-19-035784 5305

Latest XBRL company facts

One latest value per concept from companyfacts (283 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 188.73M 2026-11-04 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
dei EntityPublicFloat Entity Public Float USD 22.20M 2025-06-30 2025 FY 10-K 2026-03-18 0001628280-26-019438
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 1.40M 2025-01-01 2025-12-31 DEF 14A 2026-04-27 0001628280-26-027621
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 995,718 2025-01-01 2025-12-31 DEF 14A 2026-04-27 0001628280-26-027621
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 3.73M 2025-01-01 2025-12-31 DEF 14A 2026-04-27 0001628280-26-027621
ecd PeoTotalCompAmt PeoTotalCompAmt USD 1.93M 2025-01-01 2025-12-31 DEF 14A 2026-04-27 0001628280-26-027621
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 87.63 2025-01-01 2025-12-31 DEF 14A 2026-04-27 0001628280-26-027621
ffd NetFeeAmt NetFeeAmt USD 1,045.74 2026-11-09 S-3 2026-11-10 0001193125-26-454506
ffd TtlFeeAmt TtlFeeAmt USD 1,045.74 2026-11-09 S-3 2026-11-10 0001193125-26-454506
ffd TtlOfferingAmt TtlOfferingAmt USD 250.00M 2026-11-09 S-3 2026-11-10 0001193125-26-454506
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-11-09 S-3 2026-11-10 0001193125-26-454506
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-11-09 S-3 2026-11-10 0001193125-26-454506
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 5.86M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap AccountsReceivableRelatedParties Accounts Receivable, Related Parties USD 0 2021-12-31 2021 FY 10-K 2022-03-15 0000950170-22-003668
us-gaap AccruedIncomeTaxes Accrued Income Taxes USD 129,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 4.49M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 670,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 1.65M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -1.03M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 574.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 356.08M 2022-09-30 2022 Q3 10-Q 2022-11-08 0001628280-22-028772
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 1.28M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 3.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 52.51M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap Assets Assets USD 222.24M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap AssetsCurrent Assets, Current USD 141.96M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 653,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 148.26M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value USD 5.00M 2018-12-31 2018 FY 10-K 2019-03-07 0001564590-19-006804
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 147.61M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 122.79M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap AvailableForSaleSecuritiesDebtSecuritiesNoncurrent Debt Securities, Available-for-sale, Noncurrent USD 24.82M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap AvailableForSaleSecuritiesGrossRealizedGainLossNet Available-for-sale Securities, Gross Realized Gain (Loss) USD 0 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-10 0000950170-21-004066
us-gaap AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions, Greater than or Equal to One Year Investment 0 2018-12-31 2018 FY 10-K 2019-03-07 0001564590-19-006804
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 0 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-09 0001628280-22-021759
us-gaap Cash Cash USD 3.32M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 13.81M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 166.67M 2022-03-31 2022 Q1 10-Q 2022-05-10 0000950170-22-008739
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 10.87M 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-07 0001564590-19-030178
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 161.42M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 15.74M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -5.69M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001636651-25-000012
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 658,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 10.49M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 0.91 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 315.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 188.72M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 188.72M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap CommonStockValue Common Stock, Value, Issued USD 189,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -53.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 718,000 2025-09-30 2025 Q3 10-Q 2025-11-12 0001636651-25-000012
us-gaap CostOfGoodsAndServicesSoldDepreciationAndAmortization Cost, Depreciation and Amortization USD 66,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap CurrentFederalStateAndLocalTaxExpenseBenefit Current Federal, State and Local, Tax Expense (Benefit) USD 0 2020-01-01 2020-09-30 2021 Q3 10-Q 2021-11-10 0000950170-21-004066
us-gaap DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction USD 0 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-09 0001628280-22-021759
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions Investment 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months USD 5.00M 2018-12-31 2019 FY 10-K 2020-03-11 0001564590-20-010108
us-gaap DebtSecuritiesAvailableForSaleRealizedGainLoss Debt Securities, Available-for-sale, Realized Gain (Loss) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap DebtSecuritiesAvailableForSaleUnrealizedGainLoss Debt Securities, Available-for-sale, Unrealized Gain (Loss) USD 223,649 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-09 0001628280-22-021759
us-gaap DeferredCostsCurrent Deferred Costs, Current USD 242,673 2016-12-31 2017 FY 10-K 2018-03-29 0001564590-18-007152
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 5.80M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-15 0001564590-21-013016
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 0 2021-12-31 2021 FY 10-K 2022-03-15 0000950170-22-003668
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 0 2021-12-31 2021 FY 10-K 2022-03-15 0000950170-22-003668
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 500,000 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-13 0001564590-21-027623
us-gaap DeferredTaxAssetsCharitableContributionCarryforwards Deferred Tax Assets, Charitable Contribution Carryforwards USD 2,000 2025-12-31 2025 FY 10-K 2026-03-18 0001628280-26-019438
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 4.55M 2025-12-31 2025 FY 10-K 2026-03-18 0001628280-26-019438
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 92.63M 2023-12-31 2023 FY 10-K 2024-03-08 0001628280-24-009809
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-18 0001628280-26-019438
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 70.23M 2025-12-31 2025 FY 10-K 2026-03-18 0001628280-26-019438
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 2.21M 2025-12-31 2025 FY 10-K 2026-03-18 0001628280-26-019438
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation USD 28,243 2021-12-31 2021 FY 10-K 2022-03-15 0000950170-22-003668
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 5.09M 2025-12-31 2025 FY 10-K 2026-03-18 0001628280-26-019438
us-gaap DeferredTaxAssetsTaxDeferredExpenseOther Deferred Tax Assets, Tax Deferred Expense, Other USD 97,494 2022-12-31 2023 FY 10-K 2024-03-08 0001628280-24-009809
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 91.09M 2025-12-31 2025 FY 10-K 2026-03-18 0001628280-26-019438
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 2.50M 2025-12-31 2025 FY 10-K 2026-03-18 0001628280-26-019438
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 5.61M 2025-12-31 2025 FY 10-K 2026-03-18 0001628280-26-019438
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 48,000 2025-12-31 2025 FY 10-K 2026-03-18 0001628280-26-019438
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 172,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap Depreciation Depreciation USD 66,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 66,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap Dividends Dividends USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap DueFromRelatedPartiesCurrent Due from Related Parties, Current USD 7,369 2016-12-31 2017 FY 10-K 2018-03-29 0001564590-18-007152
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 0 2021-12-31 2021 FY 10-K 2022-03-15 0000950170-22-003668
us-gaap DueToRelatedPartiesNoncurrent Due to Related Parties, Noncurrent USD 0 2021-12-31 2021 FY 10-K 2022-03-15 0000950170-22-003668
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.24 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-12 0001628280-24-046868
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.35 2019-10-01 2019-12-31 2019 FY 10-K 2020-03-11 0001564590-20-010108
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.24 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-12 0001628280-24-046868
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure -0.005 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001628280-26-019438
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001628280-26-019438
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure 0.111 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-11 0001628280-25-011844
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0.011 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-10 0000950170-21-004066
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderOtherAmount EffectiveIncomeTaxRateReconciliationCrossBorderOtherAmount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001628280-26-019438
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderOtherPercent EffectiveIncomeTaxRateReconciliationCrossBorderOtherPercent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001628280-26-019438
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0.003 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-11 0001628280-25-011844
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure -0.013 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-08 0001628280-24-009809
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001628280-26-019438
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.068 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001628280-26-019438
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0.003 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001628280-26-019438
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001628280-26-019438
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-11 0001628280-25-011844
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD -194,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 2.47M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 13.50M 2026-03-31 2026 Q1 10-Q 2026-05-12 0001628280-26-033864
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 9.50M 2025-09-30 2025 Q3 10-Q 2025-11-12 0001636651-25-000012
us-gaap EquityMethodInvestmentOtherThanTemporaryImpairment Equity Method Investment, Other than Temporary Impairment USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-11 0001628280-25-011844
us-gaap EquityMethodInvestments Equity Method Investments USD 5.10M 2022-12-31 2022 FY 10-K 2023-03-13 0001628280-23-007648
us-gaap EquitySecuritiesFvNiUnrealizedGainLoss Equity Securities, FV-NI, Unrealized Gain (Loss) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap EquitySecuritiesFvNiUnrealizedLoss Equity Securities, FV-NI, Unrealized Loss USD 1.30M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-11 0001628280-25-011844
us-gaap EquitySecuritiesWithoutReadilyDeterminableFairValueAmount Equity Securities without Readily Determinable Fair Value, Amount USD 42.69M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Cumulative Amount USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap FairValueOptionChangesInFairValueGainLoss1 Fair Value, Option, Changes in Fair Value, Gain (Loss) USD -872,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap GainContingencyUnrecordedAmount Gain Contingency, Unrecorded Amount USD 1.80M 2024-12-31 2024 FY 10-K 2025-03-11 0001628280-25-011844
us-gaap GainLossOnDispositionOfIntangibleAssets Gain (Loss) on Disposition of Intangible Assets USD -4,610 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-11 0001564590-20-010108
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 19.81M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -17.77M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001628280-26-019438
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -52.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 361,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001628280-26-019438
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -3.66M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001628280-26-019438
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 7,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001628280-26-019438
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 1.19M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001628280-26-019438
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD -52,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001628280-26-019438
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 2,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001628280-26-019438
us-gaap IncreaseDecreaseDueFromAffiliates Increase (Decrease) Due from Affiliates USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-13 0001628280-23-007648
us-gaap IncreaseDecreaseInAccountsPayableTrade Increase (Decrease) in Accounts Payable, Trade USD 3.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -409,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-13 0001628280-23-007648
us-gaap IncreaseDecreaseInDeferredLiabilities Increase (Decrease) in Deferred Liabilities USD 229,000 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-07 0001564590-19-006804
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap IncreaseDecreaseInDueFromRelatedParties Increase (Decrease) in Due from Related Parties USD -7,369 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-07 0001564590-19-006804
us-gaap IncreaseDecreaseInDueToRelatedParties Increase (Decrease) in Due to Related Parties USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-13 0001628280-23-007648
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -1.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 0 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-12 0001628280-24-046868
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 604,646 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-29 0001564590-18-007152
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 624,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap IncreaseDecreaseInPrepaidRent Increase (Decrease) in Prepaid Rent USD -12,338 2016-01-01 2016-09-30 2017 Q3 10-Q 2017-11-09 0001564590-17-023274
us-gaap IncreaseDecreaseInSecurityDeposits Increase (Decrease) in Security Deposits USD 56,943 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-08 0001628280-22-028772
us-gaap IncrementalCommonSharesAttributableToCallOptionsAndWarrants Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants shares 565,538 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-10 0000950170-21-004066
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 3.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap LandSubjectToGroundLeases Land Subject to Ground Leases sqft 19,000 2022-03-10 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 15.24M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 4.94M 2025-12-31 2025 FY 10-K 2026-03-18 0001628280-26-019438
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 2.32M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 2.47M 2025-12-31 2025 FY 10-K 2026-03-18 0001628280-26-019438
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 2.47M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 2.47M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 2.47M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 579,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap Liabilities Liabilities USD 23.57M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 222.24M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap LiabilitiesCurrent Liabilities, Current USD 11.86M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap LiabilityForUncertainTaxPositionsCurrent Liability for Uncertainty in Income Taxes, Current USD 0 2021-12-31 2021 FY 10-K 2022-03-15 0000950170-22-003668
us-gaap LongTermInvestments Long-term Investments USD 20.91M 2025-09-30 2025 Q3 10-Q 2025-11-12 0001636651-25-000012
us-gaap LossContingencyLossInPeriod Loss Contingency, Loss in Period USD 1.80M 2024-07-01 2024-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap MoneyMarketFundsAtCarryingValue Money Market Funds, at Carrying Value USD 36.70M 2023-09-30 2023 Q3 10-Q 2023-11-03 0001628280-23-036564
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 117.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 75,401 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-08 0001564590-18-011934
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -69.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -45.07M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-08 0001564590-18-011934
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -47.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -12.93M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-08 0001564590-18-011934
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -52.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -17.18M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-12 0001628280-24-046868
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -17.14M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001628280-26-019438
us-gaap NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification (Deprecated 2020-01-31) USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-29 0001564590-18-007152
us-gaap NoninterestExpenseOfferingCost Noninterest Expense Offering Cost USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-15 0000950170-22-003668
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 854,786 2020-01-01 2020-06-30 2020 Q2 10-Q 2020-08-10 0001564590-20-038644
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap OperatingExpenses Operating Expenses USD 56.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -55.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap OperatingLeaseCost Operating Lease, Cost USD 1.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 16.25M 2022-09-30 2022 Q3 10-Q 2022-11-08 0001628280-22-028772
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 1.51M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 10.84M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap OperatingLeasePayments Operating Lease, Payments USD 2.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 10.66M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 954,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 56,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 0 2025-12-31 2025 FY 10-K 2026-03-18 0001628280-26-019438
us-gaap OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent USD -277,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD -192,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -2,469 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-15 0000950170-22-003668
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -633,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap OtherNoncashIncome Other Noncash Income USD 733,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 3.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap OtherOperatingIncomeExpenseNet Other Operating Income (Expense), Net USD 711,009 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-08 0001628280-22-028772
us-gaap ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic Participating Securities, Distributed and Undistributed Earnings (Loss), Basic USD -272,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001628280-26-019438
us-gaap ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted Participating Securities, Distributed and Undistributed Earnings (Loss), Diluted USD -458,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-18 0001628280-26-019438
us-gaap PaymentOfFinancingAndStockIssuanceCosts Payment of Financing and Stock Issuance Costs USD 505,229 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-06-13 0001193125-17-202470
us-gaap PaymentsForRent Payments for Rent USD 2.30M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-08 0001628280-24-009809
us-gaap PaymentsForSoftware Payments for Software USD 40,439 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-06-13 0001193125-17-202470
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-13 0001628280-23-007648
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 110.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap PaymentsToAcquireEquityMethodInvestments Payments to Acquire Equity Method Investments USD 1.63M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-15 0000950170-22-003668
us-gaap PaymentsToAcquireLongtermInvestments Payments to Acquire Long-term Investments USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-11 0001628280-25-011844
us-gaap PaymentsToAcquireNotesReceivable Payments to Acquire Notes Receivable USD 1.00M 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-09 0001628280-22-021759
us-gaap PaymentsToAcquireProductiveAssets Payments to Acquire Productive Assets USD 5,895 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-07 0001564590-19-030178
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001628280-26-019438
us-gaap PaymentsToDevelopSoftware Payments to Develop Software USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001628280-26-019438
us-gaap PreferredStockDividendRatePercentage Preferred Stock, Dividend Rate, Percentage pure 0.08 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-29 0001564590-18-007152
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2025-12-31 2025 FY 10-K 2026-03-18 0001628280-26-019438
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2025-12-31 2025 FY 10-K 2026-03-18 0001628280-26-019438
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2025-12-31 2025 FY 10-K 2026-03-18 0001628280-26-019438
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2025-12-31 2025 FY 10-K 2026-03-18 0001628280-26-019438
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 5.36M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap PrepaidExpenseNoncurrent Prepaid Expense, Noncurrent USD 0 2021-12-31 2021 FY 10-K 2022-03-15 0000950170-22-003668
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 69.75M 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-07 0001564590-19-006804
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 10.49M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 70.64M 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-29 0001564590-18-007152
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 56.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised USD 73,104 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-07 0001564590-19-030178
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 46.70M 2020-08-01 2020-08-31 2021 Q1 10-Q 2021-05-13 0001564590-21-027623
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-15 0000950170-22-003668
us-gaap ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities Proceeds from Sale and Maturity of Debt Securities, Available-for-sale USD 41.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap ProceedsFromSaleOfLongtermInvestments Proceeds from Sale of Long-term Investments USD 70,000 2025-02-01 2025-02-28 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 667,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 168,577 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-08 0001628280-22-028772
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 50.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 186,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party USD 750,000 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-10 0000950170-22-008739
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 36.83M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap RestrictedCash Restricted Cash USD 1.93M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminated Restructuring and Related Cost, Number of Positions Eliminated eliminated 17 2024-04-01 2024-06-30 2024 Q3 10-Q 2024-11-12 0001628280-24-046868
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent Restructuring and Related Cost, Number of Positions Eliminated, Period Percent pure 0.43 2024-04-01 2024-06-30 2024 Q3 10-Q 2024-11-12 0001628280-24-046868
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -374.49M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 735,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 1.46M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-08 0001628280-22-028772
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-08 0001628280-24-009809
us-gaap RoyaltyExpense Royalty Expense USD 700,000 2025-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap SecurityDeposit Security Deposit USD 39,091 2022-09-30 2022 Q3 10-Q 2022-11-08 0001628280-22-028772
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 2.98M 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-06-13 0001193125-17-202470
us-gaap SettlementLiabilitiesCurrent Settlement Liabilities, Current USD 750,000 2022-03-31 2022 Q1 10-Q 2022-05-10 0000950170-22-008739
us-gaap SeveranceCosts1 Severance Costs USD 893,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 3.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 4.44M 2017-09-30 2017 Q3 10-Q 2017-11-09 0001564590-17-023274
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 1.56M 2017-09-30 2017 Q3 10-Q 2017-11-09 0001564590-17-023274
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 7.64 2017-09-30 2017 Q3 10-Q 2017-11-09 0001564590-17-023274
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 324,312 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-10 0000950170-21-004066
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 1.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 4.44 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 2.37M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-13 0001628280-23-007648
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 7.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 14.55M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 22.92M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 2.35 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 5.33M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number shares 12.30M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price USD/shares 2.91 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 10.75M 2017-09-30 2017 Q3 10-Q 2017-11-09 0001564590-17-023274
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 50,000 2021-06-30 2021 Q2 10-Q 2021-08-16 0000950170-21-001457
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 8.04 2017-09-30 2017 Q3 10-Q 2017-11-09 0001564590-17-023274
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 1.04M 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-06-13 0001193125-17-202470
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 1.05 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 5.56 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-13 0001628280-23-007648
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 1.89 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001628280-26-019438
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 198.67M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.465 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-29 0001564590-18-007152
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 576,460 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 0 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-13 0001628280-23-007648
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 15,000 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072495
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 46.73M 2020-07-01 2020-09-30 2021 Q3 10-Q 2021-11-10 0000950170-21-004066
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 4.01M 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-29 0001564590-18-007152
us-gaap StockIssuedDuringPeriodValuePurchaseOfAssets Stock Issued During Period, Value, Purchase of Assets USD 7.30M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-13 0001628280-23-007648
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 81,629 2022-07-01 2022-09-30 2022 Q3 10-Q 2022-11-08 0001628280-22-028772
us-gaap UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic Undistributed Earnings (Loss) Allocated to Participating Securities, Basic USD 0 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-12 0001628280-24-046868
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD 21.05M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001628280-26-019438
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2025-12-31 2025 FY 10-K 2026-03-18 0001628280-26-019438
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-03-18 0001628280-26-019438
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 1.60M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001628280-26-019438
us-gaap VariableLeaseCost Variable Lease, Cost USD 0 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-12 0001628280-26-033864
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 0 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-08 0001628280-22-028772
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 70.87M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-12 0001628280-24-046868
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 24.63M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-07 0001564590-19-006804
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 70.87M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-12 0001628280-24-046868

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →